With its new investment in Juno Therapeutics, JUNO 15.18 % Celgene CELG 0.72 % is swinging for the fences. It is a good thing for shareholders, then, that Celgene can afford to strike out.
Why is Celgene So Darn Expensive?
Juno Therapeutics PT Lowered to $54.00 (JUNO)
Dakota Financial News